Kailera Therapeutics, Inc.

Contributing Author

Recent Articles by Kailera Therapeutics, Inc.

13 hours	Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions KLRA -5.34% GlobeNewswire
Apr-20	Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares KLRA -5.35% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information